J&J to pay millions of dollars in fine due to deceptive marketing
South Carolina’s high court ordered Johnson & Johnson (J&J) to pay a fine of $136 million for deceptively marketing its anti-psychotic drug Risperdal and concealing its hazards, Reuters reported on Thursday, February 26.
Justice John Kittredge’s ruling stated that J&J’s desire for greater market share and revenue compelled the company to grievously violate South Carolina law. However, the Supreme Court’s decision has cut the fine from $327 million to more than half, citing a three-year statute of limitations.
In 2007, the state filed a complaint against the Risperdal maker after learning about the misleading information contained in its inserts since 1994, and its reportedly misleading letters to prescribing physicians in 2003.
Dangerous pharmaceuticals such as Risperdal are considered an enormous safety threat for an already vulnerable population. If you or someone you know has suffered unduly because of this drug, we at Williams Kherkher might be able to help you seek remunerations. Call us at (800) 220-9341 and tell us about your circumstances today.